Drug Class
IDH inhibitor
Type
ingredient
Active Ingredient
vorasidenib
📋Overview
Vorasidenib is a targeted therapy drug that inhibits specific enzymes known as isocitrate dehydrogenase 1 and 2 (IDH1/2). It is primarily associated with the treatment of certain types of brain tumors, particularly low-grade gliomas that have mutations in these enzymes. By blocking the abnormal activity of mutated IDH enzymes, vorasidenib aims to interfere with cancer cell growth. Research into its use is ongoing, especially in the context of brain cancers with specific genetic alterations.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for vorasidenib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.